
Shares of medical equipment maker Revvity RVTY.N rise 2% to $111 premarket
Co forecasts 2026 adjusted profit per share of $5.35 to $5.45 vs analysts' average estimate of $5.32 - LSEG data
RVTY reports Q4 adj. profit of $1.70/shr vs estimates of $1.55/shr
Co's quarterly revenue of $772.1 million beats analysts' expectation of $761.3 million
Up to last close, stock down 14.3% in last 12 months